Biodit AD (XBUL:BDT) Notes Receivable: €0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biodit AD Notes Receivable?

Biodit AD XBUL:BDT Notes Receivable is €0.00 Mil as of . 20. The stock has 1 warning sign investors should review.

Biodit AD's Notes Receivable for the quarter that ended in . 20 was €0.00 Mil.

Biodit AD Notes Receivable Historical Data

* Premium members only.

The historical data trend for Biodit AD's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodit AD Notes Receivable Chart

Biodit AD Annual Data
Trend
Notes Receivable

Biodit AD Semi-Annual Data
Notes Receivable

Biodit AD Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.00 Mil mean?
Biodit AD (XBUL:BDT) has a Notes Receivable of €0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Biodit AD and its competitors.
Is Biodit AD's Notes Receivable too high?
Biodit AD's current Notes Receivable is €0.00 Mil.
How does Biodit AD's Notes Receivable compare to ?
Biodit AD's Notes Receivable of €0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Business Services company?
A good Notes Receivable depends on the Business Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Biodit AD and its competitors. Biodit AD's current Notes Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biodit AD stock overvalued right now?
Biodit AD (XBUL:BDT) has a current Notes Receivable of €0.00 Mil. The current Notes Receivable is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Biodit AD (XBUL:BDT), the current Notes Receivable is €0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biodit AD Business Description

Comparable Companies
Address 125 Kliment Ohridski Boulevard, Sofia, BGR, 1756
Biodit AD is engaged in development and production of biometric systems for access control, security, and working hours. Its systems consist of devices that combine the latest technologies for fingerprints. The product offerings of the company include Olock Wbls, Inside Wbls, and Gateway among others.